Only if ..: Gefitinib will only work if there is a egfr mutation detected on the cancer. It will not be effective if there is no egfr mutation detected.
Answered 8/17/2012
5.8k views
Not used: Really not used anymore since the company sponsored trial showed no benefit. Now tarceva (erlotinib) has essentially replaced iressa (gefitinib). If patients have a mutation in egfr (not kras), probably better than chemotherapy. There was a trial that did show a benefit after chemotherapy in patients with a mutation. Hope this helps.
Answered 8/29/2012
5.6k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question